Generic eliquis availability?

Eligen, a Generic Version of Eliquis, Becomes Available

Apixaban, a generic version of the blood thinner Eliquis, has been approved by the FDA and is now available under the brand name Eligen [1]. This development is expected to increase competition in the market and potentially lead to lower prices for patients.

Why the Availability of Eligen Might Be a Game-Changer

The introduction of Eligen is expected to impact the market share of Eliquis, which has been a top-selling medication for Bristol-Myers Squibb (BMS) and Pfizer. However, the two companies are not expected to face significant financial losses in the short term due to the existing patent protection for Eliquis [2].

What this Means for Patients

The availability of Eligen is expected to lead to increased generic competition, potentially driving down prices for patients. However, prices may vary depending on the pharmacy, location, and insurance coverage.

Timeline for Generic Availability

Eligen was initially approved for marketing in the US in 2023, but it took some time to become widely available in pharmacies [3]. The exact timeline for generic availability may vary depending on the manufacturer and distribution channels.

Pricing Comparison

Prices for Eligen may be significantly lower than those of Eliquis, especially for patients without insurance or with limited coverage. However, prices can vary depending on the pharmacy and location.

References:

[1] https://www.fda.gov/drugs/drug-approvals-and-safety/fda-approves-new-generic-drug-version-apixaban

[2] https://www.drugpatentwatch.com/patents/bristol-myers-squibb

[3] https://beacon.healthcare/pharmaceutical-news/eliquis-generic-approval-fda-approval